Evidence map›Paper›PMID 36693542›Full record

ArticleDiabetes research and clinical practice2023

All-cause mortality after hypoglycemic and hyperglycemic emergencies among U.S. adults with diabetes, 2011-2020.

Rozalina G McCoy, Jeph Herrin, Rodolfo J Galindo, Kavya Sindhu Swarna, Guillermo E Umpierrez, Sherita Hill Golden, Patrick J O'Connor

Abstract read
In one paragraph

Article in Diabetes research and clinical practice, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed.

  1. Article
  2. Observational
  3. Review
  4. Observational
  5. Article
  6. Review
  7. Article
  8. Article
  9. A National Physician Survey Examining Switching From Sulfonylureas or Insulin to Newer Diabetes Medications.Clinical diabetes : a publication of the American Diabetes Association · 2025
    Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Out of Sight, Out of Mind: A Call to Action for the Treatment of Hypoglycemia.Clinical diabetes : a publication of the American Diabetes Association · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Rozalina G McCoyDivision of Community Internal Medicine, Geriatrics, and Palliative Care, Department of Medicine, Mayo Clinic, Rochester, MN, United States; Mayo Clinic Robert D. and Patricia E. Kern Center for the Science of Health Care Delivery, 200 First Street SW, Rochester, MN, United States. Electronic address: mccoy.rozalina@mayo.edu.
Jeph HerrinSection of Cardiovascular Medicine, Yale School of Medicine, New Haven, CT, United States.
Rodolfo J GalindoDivision of Endocrinology, Department of Medicine, Comprehensive Diabetes Center at Lennar Medical Foundation, University of Miami, Miami, FL, United States.
Kavya Sindhu SwarnaMayo Clinic Robert D. and Patricia E. Kern Center for the Science of Health Care Delivery, 200 First Street SW, Rochester, MN, United States; OptumLabs, Eden Prairie, MN, United States.
Guillermo E UmpierrezEmory University School of Medicine, Department of Medicine, Division of Endocrinology, Grady Memorial Hospital, Atlanta, GA, United States.
Sherita Hill GoldenDivision of Endocrinology, Diabetes, and Metabolism, Department of Medicine Johns Hopkins Medicine, Baltimore, MD, United States; Office of Diversity, Inclusion, and Health Equity, Johns Hopkins Medicine, Baltimore, MD, United States.
Patrick J O'ConnorCenter for Chronic Care Innovation, HealthPartners Institute, Minneapolis, MN, United States.

Funding

Predicting the Risk of Severe Hypoglycemic and Hyperglycemic Events in Adults with DiabetesK23DK114497 · NIDDK · MAYO CLINIC ROCHESTER · PI MCCOY, ROZALINA GRUBINA · 2017 to 2021
$846k
NIDDK NIH HHS K23 DK114497
6 · The paper itself

Abstract

Estimated all-cause mortality within 30-days of hypoglycemic emergencies is 0.8 % in adults with type 1 diabetes and 1.7 % with type 2 diabetes; and within 30-days of hyperglycemic emergencies, it is 1.2 % with type 1 diabetes and 2.8 % with type 2 diabetes. These rates changed little between 2011 and 2020.

Indexed as

Diabetes Mellitus, Type 1Diabetes Mellitus, Type 2Diabetic KetoacidosisAdultEmergenciesHumansHypoglycemic AgentsHypoglycemic Agents

Identifiers

PMID36693542
PMCPMC10023431

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.